Biotech · Public company · Washington, DC, US

60 Degrees Pharmaceuticals, Inc.

Ticker SXTP · SEC CIK 0001946563

Track this companyFree. Adds 60 Degrees Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials42 recruiting or active

Pipeline programs4From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline4

TafenoquinePhase 2 · BabesiosisClinicalTrials.gov · fetched Nov 12, 2026
TafenoquinePhase 2 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Tafenoquine 100mgPhase 2 · Chronic BabesiosisClinicalTrials.gov · fetched Nov 12, 2026
Tafenoquine Oral TabletPhase 2 · COVID 19 DiseaseClinicalTrials.gov · fetched Nov 12, 2026

B-FREE Chronic Babesiosis StudyPHASE2 · RECRUITING · started Nov 18, 2025ClinicalTrials.gov NCT06656351 · fetched Nov 12, 2026
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for BabesiosisPHASE2 · RECRUITING · started Jun 17, 2024ClinicalTrials.gov NCT06207370 · fetched Nov 12, 2026
Tafenoquine in Patients With Mild to Moderate COVID-19PHASE2 · COMPLETED · started Feb 19, 2021ClinicalTrials.gov NCT04533347 · fetched Nov 12, 2026
Long-Term Safety Study of TafenoquinePHASE2 · COMPLETED · started Oct 5, 2017ClinicalTrials.gov NCT03320174 · fetched Nov 12, 2026